Use of dark chocolate for diabetic patients: a review of the literature and current evidence

Dietary changes are a major lifestyle factor that can influence the progression of chronic diseases such as diabetes. Recently, flavanols, a subgroup of plant-derived phytochemicals called flavonoids, have gained increasing attention, due to studies showing an inverse correlation between dietary int...

Full description

Saved in:
Bibliographic Details
Published inJournal of community hospital internal medicine perspectives Vol. 7; no. 4; pp. 218 - 221
Main Authors Shah, Syed Raza, Alweis, Richard, Najim, Najla Issa, Dharani, Amin Muhammad, Jangda, Muhammad Ahmed, Shahid, Maira, Kazi, Ahmed Nabeel, Shah, Syed Arbab
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 01.10.2017
Greater Baltimore Medical Center
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Dietary changes are a major lifestyle factor that can influence the progression of chronic diseases such as diabetes. Recently, flavanols, a subgroup of plant-derived phytochemicals called flavonoids, have gained increasing attention, due to studies showing an inverse correlation between dietary intake of flavanols and incidence of diabetes. Flavanoids in the cocoa plant may ameliorate insulin resistance by improving endothelial function, altering glucose metabolism, and reducing oxidative stress. Oxidative stress has been proposed as the main culprit for insulin resistance. The well-established effects of cocoa on endothelial function also points to a possible effect on insulin sensitivity. The relationship between insulin resistance and endothelial function is a reciprocal one. Overall, the evidence from these studies suggests that cocoa may be useful in slowing the progression to type 2 diabetes and ameliorating insulin resistance in metabolic syndrome. Additionally, results from several small studies indicate that cocoa may also have therapeutic potential in preventing cardiovascular complications in diabetic patients. Studies highlighting the potential of cocoa-containing diets, in large-randomized controlled trials should be performed which might give us a better opportunity to analyze the potential health-care benefit for reducing the risk of complications in diabetic patients at molecular level.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:2000-9666
2000-9666
DOI:10.1080/20009666.2017.1361293